Re-thinking funding success in Alzheimer’s disease research: Why good science is not enough

Key Points

• Funding success in Alzheimer's disease research depends on more than just scientific merit, revealing systemic issues.
• Strong correlation found between research quality metrics and funding rates, with significant discrepancies noted.
• Assessment of funding strategies used in Alzheimer’s disease research, emphasizing gaps in current practices and metrics.
• Highlights the urgent need for evolving criteria, as traditional metrics may overlook impactful work in Alzheimer's disease research.